. 2013 Mar 28;81(2):309–327. doi: 10.3797/scipharm.1302-08
© 2013 Faridoon and Ul Islam; licensee Österreichische Apotheker-Verlagsgesellschaft m. b. H., Vienna, Austria.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Fig. 7.
Hydroxamates as FEZ-1 inhibitor